Kohei Ogawa

13PUBLICATIONS
16CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 04, 2025
Clinical significance of postoperative cardiothoracic ratio for postoperative pleural effusion following hepatectomy.

Akimasa Sakamoto, Katsunori Sakamoto, Takahiro Hikida

|May 16, 2025
Novel modified frailty index predicts completion of adjuvant chemotherapy in resectable pancreatic cancer in a dual center study.

Naotake Funamizu, Shozo Mori, Akimasa Sakamoto

|Jun 02, 2024
Impact of tumor proximity to vessel on conversion in laparoscopic liver resection: A retrospective cohort study.

Akimasa Sakamoto, Kohei Ogawa, Mikiya Shine

|Mar 13, 2024
C-Reactive Protein-to-Albumin Ratio to Predict Tolerability of S-1 as an Adjuvant Chemotherapy in Pancreatic Cancer.

Naotake Funamizu, Akimasa Sakamoto, Takahiro Hikida

|Oct 12, 2023
Geriatric Nutritional Risk Index Predicts Tolerability of S-1 as Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma.

Akimasa Sakamoto, Naotake Funamizu, Mikiya Shine

|Sep 12, 2023
Living Donor Liver Transplantation in Patients with Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibodies Using Preoperative Desensitization Therapy According to Intensity of Donor-Specific Antibodies: A Single-Center Study.

Kohei Ogawa, Kei Tamura, Katsunori Sakamoto

Pageof 3

Frequent Collaborators

13 joint publications

Yasutsugu Takada

9 joint publications

Katsunori Sakamoto

8 joint publications

Masahiko Honjo

8 joint publications

Naotake Funamizu